The largest database of trusted experimental protocols

8 protocols using atcc pcs 100 010

1

Culturing Human Endothelial and Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human umbilical vein vascular endothelium cells (HUVEC, ATCC® PCS‐100‐010™) were obtained from ATCC and maintained in endothelial cell growth medium including growth supplements (EGM, CC‐3124, Lonza). The MCF‐7 luminal‐like breast cancer cell line was obtained from the cell bank of the Chinese Academy of Sciences (Shanghai, China) and maintained in Dulbecco's Modified Eagle's Medium (DMEM) with high glucose supplemented with 100 U/mL of penicillin, 100 μg/mL streptomycin and 10% foetal bovine serum (FBS). The cells were incubated at 37°C in a humidified incubator supplemented with 5% CO2. All the siRNAs were transfected into HUVECs using Lipofectamine 3000 (Invitrogen) at a final concentration of 100 nmol/L.
+ Open protocol
+ Expand
2

Endothelial Differentiation of Adipose Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The differentiation process started at 50–60% confluency of AMSCs. The AMSC culture was stimulated with endothelial growth medium (EGM) composed of Endothelial Basal Medium-2 (Gibco, Grand Island, NY, USA), growth supplements (containing hydrocortisone, human fibroblast growth factor (hFGF-b), R3-insulin-like growth factor-1 (R3-IGF-1), ascorbic acid, human epithelial growth factor (hEGF), GA-1000, heparin), 2% FBS (EGM-2 Bullet Kit; Lonza, Walkersville, MD, USA), and 50 ng/ml VEGF-165 (Peprotech, Rocky Hill, NJ, USA). The cells were maintained at 37 °C with 5% CO2/95% air and 90% relative humidity, and the medium was changed every 3 days. The cells were detached from the monolayer with 0.25% Trypsin–EDTA, and collected for analysis after 10 days of stimulation for EC differentiation.
Human umbilical vein endothelial cells (HUVECs) (ATCC® PCS-100-010™; ATCC) were used as a positive control.
+ Open protocol
+ Expand
3

Cell Line Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
The TM4 cell line was purchased from iCell Bioscience, Inc. (Shanghai, China). The HepG2 [American Type Culture Collection (ATCC)® HB-8065™] and human umbilical vein endothelial cells (HUVECs; ATCC® PCS-100-010™) cell lines were purchased from ATCC (Manassas, VA, USA). TM4 cells and HUVECs were cultured in DMEM/F12 supplemented with 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.) at 37 °C in 5% CO2. HepG2 cells were cultured in DMEM supplemented with 10% FBS at 37 °C in 5% CO2.
+ Open protocol
+ Expand
4

Overexpressing miR-200b-3p in HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs) were purchase from ATCC(ATCC®PCS-100-010). Cultures of HUVECs were grown on fibronectin-coated plates; maintained in EGM (Lonza) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin. micrONTMhsa-miR-200b-3p mimic (50 nM) or negative controls (micrON™ miRNA mimic NC #22, RIOBOBIO, Guangzhou, China) were transfected using Lipofectamine 3000 according to manufacturer’s protocol (Invitrogen). Further analysis was performed after 48 h of transfection.
+ Open protocol
+ Expand
5

HUVEC Cell Line Myricetin Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVEC cell line was purchased from American Type Culture Collection (ATCC® PCS-100-010). Myricetin was commercially obtained from Sigma-Aldrich, USA (Catalog No: M6760). All cell culture chemicals were bought either from Sigma-Aldrich or Merck. Antibody eNOS and β-actin mouse mAb were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All the other chemicals were bought either from Sigma-Aldrich, Merck or other standard suppliers.
+ Open protocol
+ Expand
6

Culturing and Maintaining Breast Cancer and Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human umbilical vein vascular endothelium cells (HUVECs, ATCC® PCS-100-010™) were purchased from American Type Culture Collection (ATCC, Manassas, USA) and maintained in endothelial cell growth medium including growth supplements (EGM, CC-3124, Lonza, Walkersville, MD, USA). 4T1 mouse breast cancer cell line and MDA-MB-231 human breast cancer cell line were obtained from the cell bank of the Chinese Academy of Sciences (Shanghai, China). The 4T1 cells were maintained in RPIM1640 (Gibco, Carlsbad, CA, USA), and MDA-MB-231 cells were cultured in L-15 (Gibco). Both RPIM1640 and L-15 media contain 10% fetal bovine serum (FBS; Gibco), 100 U/mL penicillin, and 100 μg/mL phytomycin. HUVECs and 4T1 cells were incubated at 37 °C with 5% CO2, and MDA-MB-231 cells were incubated at 37 °C without CO2.
+ Open protocol
+ Expand
7

Culturing Primary Human Umbilical Vein Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human umbilical vein endothelial cells (HUVECs; ATCC PCS-100-010; American Type Culture Collection; Manassas, VA, USA) were grown in an incubator with vascular cell basal medium (ATCC PCS-100-030) and endothelial cell growth kit-BBE (ATCC PCS-1-040) and 100 U/ml penicillin-streptomycin (Sigma-Aldrich, USA) under humidified atmosphere of 95% air and 5% CO2 at 37°C.[8 (link)]
+ Open protocol
+ Expand
8

Regulation of Pulmonary Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human pulmonary arterial smooth muscle cell (H‐PASMC; ATCC® PCS‐100‐023™) and human umbilical vein endothelial cells (HUVECs; ATCC® PCS‐100‐010™) were purchased from American Type Culture Collection (ATCC). H‐PASMC and HUVECs were cultured in Dulbecco's modified Eagle medium (4.5 g/L D‐glucose; DMEM, ScienCell), both supplemented with 10% foetal bovine serum (FBS, Gibco) and 100 units/mL penicillin/streptomycin in a humidified incubator at 37°C with 5% CO2. The miR‐508‐3p mimics, miR‐508‐3p inhibitor, normal control (NC) oligonucleotides and the small‐interfering RNA (siRNA) targeting NR4A3 mRNA kit were purchased from GenePharma. Cell transfection was performed with Lipofectamine™ 2000 transfection reagent (Invitrogen) according to the manufacturer's instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!